Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid

Khalaf Kridin; Christoph M. Hammers

doi:10.1111/bjd.21882

Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid

Khalaf Kridin
, Christoph M. Hammers

Bar-Ilan University - Azrieli Faculty of Medicine

University of Lübeck
Padeh Medical Center
Kiel University

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	843-844
Number of pages	2
Journal	British Journal of Dermatology
Volume	187
Issue number	6
DOIs	https://doi.org/10.1111/bjd.21882
State	Published - Dec 2022

Funding

Open Access funding enabled and organized by Projekt DEAL.

Access to Document

10.1111/bjd.21882

Cite this

@article{0f2bf05b65a24749b6e3ce096978adfe,

title = "Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid",

author = "Khalaf Kridin and Hammers, \{Christoph M.\}",

year = "2022",

month = dec,

doi = "10.1111/bjd.21882",

language = "אנגלית",

volume = "187",

pages = "843--844",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid

AU - Kridin, Khalaf

AU - Hammers, Christoph M.

PY - 2022/12

Y1 - 2022/12

UR - https://www.scopus.com/pages/publications/85139154186

U2 - 10.1111/bjd.21882

DO - 10.1111/bjd.21882

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 36180998

AN - SCOPUS:85139154186

SN - 0007-0963

VL - 187

SP - 843

EP - 844

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 6

ER -

Atypical clinical manifestation and protracted latency are observed in the emerging variant of checkpoint inhibitor-associated bullous pemphigoid

Funding

Access to Document

Other files and links

Cite this